title: Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.
abstract: A rigorously controlled, cell culture paradigm was used to assess the role of HIV-1 gp120 ± morphine in mediating opioid-HIV interactive toxicity in striatal neurons. Computerized time-lapse microscopy tracked the fate of individual neurons co-cultured with mixed-glia from mouse striata during opioid and gp120 exposure. Subpopulations of neurons and astroglia displayed μ-opioid receptor, CXCR4, and CCR5 immunoreactivity. While gp120 alone was or tended to be neurotoxic irrespective of whether X4-tropic gp120(IIIB), R5-tropic gp120(ADA), or dual-tropic gp120(MN) was administered, interactive toxicity with morphine differed depending on HIV-1 strain. For example, morphine only transiently exacerbated gp120(IIIB)-induced neuronal death; however, in combination with gp120(MN), morphine caused sustained increases in the rate of neuronal death compared to gp120(MN) alone that were prevented by naloxone. Alternatively, gp120(ADA) significantly increased the rate of neuron death, but gp120(ADA) toxicity was unaffected by morphine. The transient neurotoxic interactions between morphine and gp120(IIIB) were abrogated in the absence of glia suggesting that glia contribute significantly to the interactive pathology with chronic opiate abuse and neuroAIDS. To assess how mixed-glia might contribute to the neurotoxicity, the effects of morphine and/or gp120 on the production of reactive oxygen species (ROS) and on glutamate buffering were examined. All gp120 variants, and to a lesser extent morphine, increased ROS and/or decreased glutamate buffering, but together failed to show any interaction with morphine. Our findings indicate that HIV-1 strain-specific differences in gp120 are critical determinants in shaping both the timing and pattern of neurotoxic interactions with opioid drugs.
authors.affiliation: Department of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298-0613, USA.
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Podhaizer
authors.forename: Shiping
authors.initials: S
authors.lastname: Zou
authors.forename: Sylvia
authors.initials: S
authors.lastname: Fitting
authors.forename: Kimberly L
authors.initials: KL
authors.lastname: Samano
authors.forename: Nazira
authors.initials: N
authors.lastname: El-Hage
authors.forename: Pamela E
authors.initials: PE
authors.lastname: Knapp
authors.forename: Kurt F
authors.initials: KF
authors.lastname: Hauser
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001253:Astrocytes / Q000473:pathology; D018920:Coculture Techniques; D005260:Female; D005455:Fluorescent Antibody Technique; D018698:Glutamic Acid / Q000378:metabolism; D015699:HIV Envelope Protein gp120 / Q000633:toxicity*; D015497:HIV-1 / Q000502:physiology*; D051379:Mice; D008813:Mice, Inbred ICR; D009020:Morphine / Q000633:toxicity*; D009294:Narcotics / Q000633:toxicity*; D017072:Neostriatum / Q000166:cytology* / Q000187:drug effects / Q000473:pathology; D009457:Neuroglia / Q000187:drug effects / Q000473:pathology; D009474:Neurons / Q000187:drug effects / Q000473:pathology*; D011247:Pregnancy; D017382:Reactive Oxygen Species; D019713:Receptors, CCR5 / Q000378:metabolism; D019718:Receptors, CXCR4 / Q000378:metabolism; D017450:Receptors, Opioid, mu / Q000378:metabolism; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000235:genetics
chemical_list: D015699:HIV Envelope Protein gp120; D009294:Narcotics; D017382:Reactive Oxygen Species; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D017450:Receptors, Opioid, mu; D054322:tat Gene Products, Human Immunodeficiency Virus; D018698:Glutamic Acid; D009020:Morphine
references.citation: Virology. 2003 Jul 20;312(1):60-73
references.pmid: 12890621
references.citation: Virology. 2003 Apr 25;309(1):99-107
references.pmid: 12726730
references.citation: Free Radic Biol Med. 2006 Mar 15;40(6):968-75
references.pmid: 16540392
references.citation: Brain Res. 1990 Jul 9;522(2):347-53
references.pmid: 2224534
references.citation: Acta Physiol (Oxf). 2006 May-Jun;187(1-2):321-7
references.pmid: 16734769
references.citation: Adv Neuroimmunol. 1994;4(3):181-8
references.pmid: 7874385
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3117-21
references.pmid: 9501225
references.citation: Brain Res Dev Brain Res. 1993 Dec 17;76(2):189-96
references.pmid: 8149585
references.citation: Nat Rev Immunol. 2005 Jan;5(1):69-81
references.pmid: 15630430
references.citation: J Neuroimmunol. 1998 Mar 15;83(1-2):63-9
references.pmid: 9610674
references.citation: Clin Diagn Lab Immunol. 1997 Mar;4(2):127-32
references.pmid: 9067644
references.citation: J Neurovirol. 2011 Aug;17(4):291-302
references.pmid: 21735315
references.citation: J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91
references.pmid: 18040783
references.citation: J Exp Med. 1998 Jul 20;188(2):317-25
references.pmid: 9670044
references.citation: AIDS Res Hum Retroviruses. 1993 May;9(5):439-44
references.pmid: 8318270
references.citation: J Pharmacol Exp Ther. 1993 Jul;266(1):417-23
references.pmid: 8392561
references.citation: Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8051-6
references.pmid: 8755601
references.citation: Front Biosci. 2008 Jan 01;13:1294-307
references.pmid: 17981630
references.citation: J Neuroimmunol. 2010 Jul 27;224(1-2):13-21
references.pmid: 20580441
references.citation: Cell Growth Differ. 1994 Oct;5(10):1033-40
references.pmid: 7848904
references.citation: AIDS Res Hum Retroviruses. 2004 Oct;20(10):1063-71
references.pmid: 15585097
references.citation: Neuroscience. 2005;135(3):781-90
references.pmid: 16111829
references.citation: Glia. 1998 Feb;22(2):189-201
references.pmid: 9537839
references.citation: Glia. 1998 Mar;22(3):249-59
references.pmid: 9482211
references.citation: J Neurosci. 2009 Feb 25;29(8):2534-44
references.pmid: 19244528
references.citation: J Neurosci. 1996 Jul 1;16(13):4080-8
references.pmid: 8753870
references.citation: Glia. 2009 Jan 15;57(2):194-206
references.pmid: 18756534
references.citation: AIDS. 2005 Jun 10;19(9):897-905
references.pmid: 15905670
references.citation: Neurosci Lett. 2010 Nov 26;485(3):233-6
references.pmid: 20849923
references.citation: Curr HIV Res. 2005 Jul;3(3):277-88
references.pmid: 16022659
references.citation: FEBS Lett. 1995 Aug 7;369(2-3):272-6
references.pmid: 7649271
references.citation: J Neurovirol. 2002 Oct;8(5):411-9
references.pmid: 12402167
references.citation: J Neuroimmunol. 2004 Mar;148(1-2):86-96
references.pmid: 14975589
references.citation: Glia. 2005 Apr 15;50(2):91-106
references.pmid: 15630704
references.citation: Neurosci Res. 1997 Oct;29(2):121-7
references.pmid: 9359460
references.citation: Cell Death Differ. 2007 Feb;14(2):296-305
references.pmid: 16841089
references.citation: Trends Immunol. 2003 Mar;24(3):116-21
references.pmid: 12615205
references.citation: Neuroreport. 2004 Apr 9;15(5):761-3
references.pmid: 15073510
references.citation: J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S78-83
references.pmid: 12394786
references.citation: J Neurochem. 2009 Jul;110(2):662-74
references.pmid: 19457093
references.citation: J Neuroimmunol. 1999 Aug 3;98(2):185-200
references.pmid: 10430052
references.citation: J Neuroimmune Pharmacol. 2008 Dec;3(4):275-85
references.pmid: 18815890
references.citation: J Neuroimmunol. 1998 Mar 15;83(1-2):77-87
references.pmid: 9610676
references.citation: Brain. 2011 Dec;134(Pt 12):3616-31
references.pmid: 22102648
references.citation: J Neurochem. 2007 Feb;100(3):567-86
references.pmid: 17173547
references.citation: Neuropharmacology. 1991 Nov;30(11):1233-9
references.pmid: 1663598
references.citation: J Endourol. 2002 Oct;16(8):605-10
references.pmid: 12470470
references.citation: Adv Exp Med Biol. 1993;335:13-20
references.pmid: 8237587
references.citation: J Neuroimmunol. 2008 Jul 15;197(2):114-23
references.pmid: 18533278
references.citation: J Neurovirol. 2011 Feb;17(1):41-9
references.pmid: 21234828
references.citation: J Neurosci Res. 2008 Jul;86(9):2100-10
references.pmid: 18338799
references.citation: AIDS. 1990 Sep;4(9):869-73
references.pmid: 2174676
references.citation: PLoS One. 2011 Mar 24;6(3):e18116
references.pmid: 21483469
references.citation: J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S62-9
references.pmid: 12394784
references.citation: Neuroscience. 2001;102(3):555-63
references.pmid: 11226693
references.citation: J Neuroimmune Pharmacol. 2011 Dec;6(4):640-9
references.pmid: 21748284
references.citation: Brain Res Dev Brain Res. 1991 May 20;60(1):1-7
references.pmid: 1914143
references.citation: Brain. 2010 Dec;133(Pt 12):3685-98
references.pmid: 21126996
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8212-6
references.pmid: 10393974
references.citation: Brain. 1998 Nov;121 ( Pt 11):2043-52
references.pmid: 9827765
references.citation: Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):494-8
references.pmid: 8290553
references.citation: Neurotox Res. 2005 Oct;8(1-2):63-80
references.pmid: 16260386
references.citation: Neurochem Res. 1988 Feb;13(2):87-103
references.pmid: 3283589
references.citation: J Biol Chem. 1999 Jun 11;274(24):17098-102
references.pmid: 10358063
references.citation: Perspect Dev Neurobiol. 1998;5(4):437-49
references.pmid: 10533530
references.citation: J Neurosci Res. 2006 Nov 15;84(7):1588-96
references.pmid: 16983662
references.citation: J Neurovirol. 2007 Apr;13(2):160-7
references.pmid: 17505984
references.citation: J Cardiovasc Pharmacol. 2007 Jul;50(1):9-16
references.pmid: 17666910
references.citation: Clin Lab Med. 2002 Sep;22(3):703-17
references.pmid: 12244593
references.citation: J Neurochem. 1992 Sep;59(3):1145-52
references.pmid: 1322969
references.citation: J Neurochem. 1998 Apr;70(4):1376-82
references.pmid: 9523553
references.citation: J Neurovirol. 2004 Jun;10(3):141-51
references.pmid: 15204919
references.citation: J Neurochem. 1991 Nov;57(5):1470-7
references.pmid: 1655974
references.citation: Neurobiol Dis. 2006 Jul;23(1):109-19
references.pmid: 16697650
references.citation: J Biol Chem. 2005 Jul 29;280(30):27662-9
references.pmid: 15944153
references.citation: J Clin Invest. 2005 Nov;115(11):3185-92
references.pmid: 16276420
references.citation: Pharmacol Rev. 2011 Sep;63(3):772-810
references.pmid: 21752874
references.citation: Virus Res. 2005 Aug;111(2):194-213
references.pmid: 15885841
references.citation: Nature. 2001 Apr 19;410(6831):988-94
references.pmid: 11309629
references.citation: Brain Res. 1996 May 13;720(1-2):191-203
references.pmid: 8782912
references.citation: Immunopharmacology. 1995 Nov;31(1):59-71
references.pmid: 8655291
references.citation: J Neural Transm (Vienna). 2005 Jan;112(1):137-47
references.pmid: 15599612
references.citation: Neuron. 1991 Jul;7(1):111-8
references.pmid: 1676893
references.citation: Ann Neurol. 2010 Jun;67(6):699-714
references.pmid: 20517932
references.citation: Ann N Y Acad Sci. 2000;917:19-28
references.pmid: 11268344
references.citation: J Neurovirol. 2004;10 Suppl 1:91-6
references.pmid: 14982745
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14500-5
references.pmid: 9826729
references.citation: J Biol Chem. 2006 Nov 3;281(44):33749-60
references.pmid: 16954126
references.citation: Biochim Biophys Acta. 2009 Aug;1793(8):1366-71
references.pmid: 19477204
references.citation: Science. 1990 Apr 20;248(4953):364-7
references.pmid: 2326646
references.citation: Neuropharmacology. 2002 May;42(6):829-36
references.pmid: 12015209
references.citation: Eur J Pharmacol. 2004 Jan 12;483(2-3):175-86
references.pmid: 14729105
references.citation: Neuroscience. 1999;91(4):1369-78
references.pmid: 10391443
references.citation: J Neurochem. 2010 Jul;114(1):97-109
references.pmid: 20403075
references.citation: Adv Neuroimmunol. 1995;5(3):299-309
references.pmid: 8748073
references.citation: J Immunol. 2010 Oct 15;185(8):4883-95
references.pmid: 20855878
references.citation: Annu Rev Neurosci. 1984;7:223-55
references.pmid: 6324644
references.citation: J Immunol. 2002 Oct 1;169(7):3589-99
references.pmid: 12244149
references.citation: J Infect Dis. 2002 Dec 1;186 Suppl 2:S193-8
references.pmid: 12424697
references.citation: PLoS One. 2008;3(12):e4093
references.pmid: 19116667
references.citation: Pharmacol Rev. 2004 Sep;56(3):351-69
references.pmid: 15317908
references.citation: J Virol. 1991 Feb;65(2):736-42
references.pmid: 1702842
references.citation: Ann Neurol. 1997 Dec;42(6):847-56
references.pmid: 9403476
references.citation: Science. 1989 Jul 28;245(4916):415-7
references.pmid: 2569236
references.citation: J Virol. 2004 Oct;78(20):11425-8
references.pmid: 15452267
references.citation: Neuroscience. 1992;48(2):491-500
references.pmid: 1603330
references.citation: J Biol Chem. 1994 May 13;269(19):13811-6
references.pmid: 8188658
references.citation: Neuropsychopharmacology. 2006 Nov;31(11):2476-88
references.pmid: 16407899
references.citation: J Biol Chem. 1998 Sep 4;273(36):23534-41
references.pmid: 9722592
references.citation: J Neurosci Res. 1991 Aug;29(4):538-48
references.pmid: 1665190
references.citation: Am J Pathol. 2010 Sep;177(3):1397-410
references.pmid: 20651230
references.citation: Neuroscientist. 2004 Feb;10(1):40-52
references.pmid: 14987447
references.citation: Eur J Neurosci. 2010 Aug;32(4):570-8
references.pmid: 20670282
references.citation: J Virol. 2011 Nov;85(22):11601-14
references.pmid: 21900165
references.citation: J Leukoc Biol. 1999 Oct;66(4):650-8
references.pmid: 10534122
references.citation: J Pharmacol Exp Ther. 1994 Apr;269(1):198-203
references.pmid: 8169825
references.citation: Ann Neurol. 1986 Jun;19(6):525-35
references.pmid: 3014994
references.citation: J Psychopharmacol. 2000;14(3):222-7
references.pmid: 11106300
references.citation: Science. 1997 Apr 4;276(5309):51-2
references.pmid: 9122710
references.citation: J Infect Dis. 2005 Mar 15;191(6):886-9
references.pmid: 15717263
references.citation: Am J Hum Genet. 2010 Nov 12;87(5):593-603
references.pmid: 21035104
references.citation: Nat Rev Neurosci. 2007 Jan;8(1):33-44
references.pmid: 17180161
references.citation: J Pharmacol Exp Ther. 2004 Jul;310(1):8-17
references.pmid: 15014135
references.citation: Exp Neurol. 2004 Aug;188(2):246-53
references.pmid: 15246824
references.citation: Int Immunopharmacol. 2006 Sep;6(9):1459-67
references.pmid: 16846840